Ikena Oncology Outlines Key Priorities and Provides
IK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort ...
Read moreIK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort ...
Read moreIRAK4 oral degrader KT-474 (SAR444656) expected to complete enrollment in both Phase 2 HS and AD studies in fourth quarter ...
Read moreANX005 Phase 3 Pivotal Data in Guillain-Barré Syndrome (GBS) On Track for First Half of 2024;Potential to be First Approved ...
Read moreRAPIDe-3, a global Phase 3 clinical study of deucrictibant for the on-demand treatment of HAE, to initiate within 1H24Results of ...
Read moreHyundai Motor Group celebrates New Year at Kia AutoLand Gwangmyeong, the first dedicated EV factory in Korea⋯ Executive Chair Euisun ...
Read moreHyundai Motor Group celebrates New Year at Kia AutoLand Gwangmyeong, the first dedicated EV factory in Korea⋯ Executive Chair Euisun ...
Read moreAlignment with FDA on Best Corrected Visual Acuity ≥ 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value ...
Read moreHosts Annual Summit and Felicitations on the Theme-Women Shaping the Techade Smt. Aruna Sundarajan, ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.